Two new α-pyrones, Exserolide G-H (1-2), together with one known metabolite, stemphypyrone (3), were isolated from the solid-substrate fermentation cultures of the plant endophytic fungus Exserohilum sp. The structures of the new compounds were elucidated primarily by analysis of NMR data. Compounds 1-3 were tested for cytotoxicity against a small panel of human carcinoma cell lines. Compound 1 showed cytotoxicity against HeLa, A549 and HCT116 cells.
The molecular formula of 1 was assigned as C 11 3 , 197.1172) . Its 1 H and 13 C NMR data ( Table 1) showed four aromatic carbons (one of which was protonated), three methyl groups including one O-methyl, three methylenes, and one carboxylic carbon (δ C 164.8). The 1 H-1 H COSY NMR data of 1 showed one isolated spin-system of C-8-C-11. HMBC correlations from the O-methyl proton signals H 3 -12 to C-4, located this O-methyl group at C-4. The correlations from H-3 to C-2, C-4 and C-5, from H 3 -7 to C-5 and C-6, and from H 2 -8 to C-4, C-5 and C-6, together with the chemical shift values of C-2 (δ = 164.8 ppm), C-3 (δ = 88.0 ppm), C-4 (δ = 171.1 ppm), C-5 (δ = 111.8 ppm) and C-6 (δ = 158.1 ppm), suggested the presence of a 5,6-substituted 4-methoxy-1H-pyran-2-one (α-pyrone) moiety [10] . From these data, the structure of 1 was proposed ( Figure 1 ). (Table 1 ) revealed nearly identical structural features to those found in 1, except that the C-7 methyl unit was replaced by an oxygenated methylene unit (δ H /δ C 4.45/59.0) in 2, indicating that 2 is an analogue of 1, which was further confirmed by relevant 1 H-1 H COSY and HMBC data. The planar structure of 2 was therefore determined as shown ( Figure 1 ).
Compounds 3 was also isolated from the crude extract and identified as the known metabolite stemphypyrone, by comparison of the NMR and MS data with those reported [9] .
Compounds 1-3 were tested for cytotoxicity against the following three human tumor cell lines, HeLa (cervical epithelial cells), A549
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Experimental
General: IR data were recorded using a Nicolet Magna-IR 750 spectrophotometer. 1 H and 13 C NMR data were acquired with Bruker Avance-500 spectrometers using solvent signals (CDCl 3 : δ H 7.26/δ C 77.2) as references. The HMQC and HMBC experiments were optimized for 145.0 and 8.0 Hz, respectively. HRESIMS data were obtained using an Agilent Accurate-Mass-Q-TOF LC/MS 6520 instrument equipped with an electrospray ionization (ESI) source. The fragmentor and capillary voltages were kept at 125 and 3500 V, respectively. Nitrogen was supplied as the nebulizing and drying gas. The temperature of the drying gas was set at 300°C. The flow rate of the drying gas and the pressure of the nebulizer were 10 L/min and 10 psi, respectively. All MS experiments were performed in positive ion mode. Full-scan spectra were acquired over a scan range of m/z 100-1000 at 1.03 spectra/s. 
Extraction and isolation:
The fermented material was extracted repeatedly with EtOAc (4 × 1.0 L), and the organic solvent was evaporated to dryness under vacuum to afford the crude extract (3.5 g), which was fractionated by silica gel vacuum liquid chromatography (VLC) using light petroleum-CH 2 Cl 2 -MeOH gradient elution. The fraction (220 mg) eluted with 100:2.5 CH 2 Cl 2 -MeOH was separated by Sephadex LH-20 CC eluting with 1:1 CH 2 Cl 2 -MeOH, and the resulting fractions were combined and purified by RP HPLC (Agilent Zorbax SB-C 18 column; 5 μm; 9.4 × 250 mm; 44% MeOH in H 2 O for 30 min, followed by 44-70% MeOH over 20 min; 2 mL/min) to afford 3 (1.0 mg, t R 29.2 min) and 2 (8.3 mg, t R 39.2 min). The fraction (165 mg) eluted with 100:3.5 CH 2 Cl 2 -MeOH was fractionated by Sephadex LH-20 CC eluting with 1:1 CH 2 Cl 2 -MeOH. The resulting fractions were further purified by RP HPLC (Agilent Zorbax SB-C 18 column; 5 μm; 9.4 × 250 mm; 75% MeOH in H 2 O for 20 min; 2 mL/min) to afford 1 (6.1 mg, t R 11.7 min). 
MTT assay:
The assay was run in triplicate. In a 96-well plate, each well was plated with (2−5) × 10 3 cells (depending on the cell multiplication rate). After cell attachment overnight, the medium was removed, and each well was treated with 100 μL of medium containing either 0.1% DMSO or appropriate concentrations of the test compounds and the positive control cisplatin (100 mM as stock solution of a compound in DMSO and serial dilutions; the test compounds showed good solubility in DMSO and did not precipitate when added to the cells). The plate was incubated for 48 h at 37°C in a humidified, 5% CO 2 atmosphere. Proliferation was assessed by adding 20 μL of MTS (Promega) to each well in the dark, followed by a 90 min incubation at 37°C. The assay plate was read at 490 nm using a microplate reader. The inhibition was calculated and plotted versus test concentrations to afford the IC 50 [11] .
